Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 2/20 | 0.49 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.41 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11432359 | 0.91 | MAP2K4 (0.46) | BCHEACHENOX1CHEK1MAP2K4 | |
| SCHEMBL6045366 | 0.84 | ALOX5 (0.65) | BCHEACHENOX1ALOX5CHEK1 | |
| SCHEMBL6959135 | 0.83 | ABCG2 (0.62) | BCHEACHENOX1ALOX5ABCG2 | |
| SCHEMBL4809585 | 0.81 | BCHE (0.44) | BCHEACHENOX1CHEK1MAPT | |
| SCHEMBL4811917 | 0.80 | CMA1 (0.44) | BCHEACHENOX1ALOX5CHEK1 | |
| SCHEMBL29485911 | 0.80 | CMA1 (0.44) | BCHEACHENOX1ALOX5CHEK1 | |
| SCHEMBL4807696 | 0.77 | AHR (0.44) | BCHEACHENOX1ALOX5CHEK1 | |
| SCHEMBL14279318 | 0.73 | ALDH1A1 (0.38) | BCHEACHENOX1ALOX5CHEK1 | |
| SCHEMBL8725779 | 0.73 | ALOX5 (0.65) | BCHEACHENOX1ALOX5CHEK1 | |
| SCHEMBL8490860 | 0.71 | MMP12 (0.41) | CHEK1MAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934312-B1 | 1,4-DISUBSTITUTED PIPERAZINES | NOVO NORDISK AS (DK) | 2003-03-19 | — | — | EP | disclosed |
| EP-0851865-B1 | 12H-Dibenzo[d,g][1,3]dioxocine derivatives | NOVO NORDISK AS (DK) | 2002-07-17 | — | — | EP | disclosed |
| US-6133268-A | 1,4-disubstituted piperazines | NOVO NORDISK A/S (DK) | 2000-10-17 | — | — | US | disclosed |
| US-6040302-A | ANTIINFLAMMATORY AGENTS TREATING RHEUMATOID ARTHRITIS, MIGRAINE OR ITCHING, INSULIN RESISTANCE IN NON-INSULIN-DEPENDENT DIABETES MELLITUS AND AGEING-ASSOCIATED OBESITY | NOVO NORDISK A/S (DK) | 2000-03-21 | — | — | US | disclosed |
| US-6004961-A | ANTIINFLAMMATORY AGENTS, ANALGESICS; NON-INSULIN-DEPENDENT DIABETES; AGE-RELATED OBESITY; DIBENZO(D,G)(1,3,6)DIOXAZOCINE DERIVATIVES | NOVO NORDISK A/S (DK) | 1999-12-21 | — | — | US | disclosed |
| US-5972925-A | 1-(3-(2-CHLORO-12H-DIBENZO(D,G)(1,3,6)DIOXAZOCIN-12-YL)-1-PROP YL)-3-PIPERIDINECARBOXYLIC ACID, FOR EXAMPLE; TREATING NEUROGENIC PAIN (IN WHICH C-FIBERS PLAY A ROLE) OR INFLAMMATION SUCH AS MIGRAINE OR DIABETIC NEUROPATHY | NOVO NORDISK A/S (DK) | 1999-10-26 | — | — | US | disclosed |
| EP-0934312-A1 | 1,4-DISUBSTITUTED PIPERAZINES | NOVO NORDISK A/S (DK) | 1999-08-11 | — | — | EP | disclosed |
| EP-0851865-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 1998-07-08 | — | — | EP | disclosed |
| WO-1998015548-A1 | 1,4-DISUBSTITUTED PIPERAZINES | NOVO NORDISK A/S (DK) | 1998-04-16 | — | — | WO | disclosed |
| WO-1997011071-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 1997-03-27 | — | — | WO | disclosed |
| US-4965259-A | CENTRAL NERVOUS SYSTEM ACTIVITY | EGIS GYOGYSZERGYAR (HU) | 1990-10-23 | — | — | US | disclosed |
| US-4229350-A | LOCAL ANESTHETICS, TREATMENT OF PARKINSON SYNDROME | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1980-10-21 | — | — | US | disclosed |
| US-4208410-A | LOCAL ANESTHETICS, ANTIPARKINSON AGENTS | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1980-06-17 | — | — | US | disclosed |